- Home
- MESA vs CMMB Comparison
MESA vs CMMB Comparison
Compare MESA & CMMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MESA
- CMMB
- Stock Information
- Founded
- MESA 1982
- CMMB 2004
- Country
- MESA United States
- CMMB Israel
- Employees
- MESA N/A
- CMMB N/A
- Industry
- MESA Air Freight/Delivery Services
- CMMB Biotechnology: Pharmaceutical Preparations
- Sector
- MESA Consumer Discretionary
- CMMB Health Care
- Exchange
- MESA Nasdaq
- CMMB Nasdaq
- Market Cap
- MESA 29.1M
- CMMB 23.6M
- IPO Year
- MESA 2018
- CMMB N/A
- Fundamental
- Price
- MESA $1.17
- CMMB $1.20
- Analyst Decision
- MESA
- CMMB Strong Buy
- Analyst Count
- MESA 0
- CMMB 2
- Target Price
- MESA N/A
- CMMB $9.00
- AVG Volume (30 Days)
- MESA 3.2M
- CMMB 167.2K
- Earning Date
- MESA 06-17-2025
- CMMB 05-08-2025
- Dividend Yield
- MESA N/A
- CMMB N/A
- EPS Growth
- MESA N/A
- CMMB N/A
- EPS
- MESA N/A
- CMMB N/A
- Revenue
- MESA $475,518,000.00
- CMMB N/A
- Revenue This Year
- MESA $15.09
- CMMB N/A
- Revenue Next Year
- MESA $16.19
- CMMB N/A
- P/E Ratio
- MESA N/A
- CMMB N/A
- Revenue Growth
- MESA N/A
- CMMB N/A
- 52 Week Low
- MESA $0.68
- CMMB $0.58
- 52 Week High
- MESA $1.89
- CMMB $2.55
- Technical
- Relative Strength Index (RSI)
- MESA 63.25
- CMMB 50.27
- Support Level
- MESA $1.05
- CMMB $1.08
- Resistance Level
- MESA $1.13
- CMMB $1.25
- Average True Range (ATR)
- MESA 0.10
- CMMB 0.11
- MACD
- MESA 0.03
- CMMB 0.04
- Stochastic Oscillator
- MESA 89.09
- CMMB 83.65
About MESA Mesa Air Group Inc.
Mesa Air Group Inc is a regional air carrier providing scheduled passenger service. It provides scheduled passenger service to 86 cities in 36 states, the District of Columbia, Canada, Cuba, and Mexico as well as cargo services out of Cincinnati/Northern Kentucky International Airport. Flights are operated as American Eagle, United Express, or DHL Express flights to the terms of capacity purchase agreements with American and United and a flight services agreement with DHL. The business has a presence in domestic hubs and cities, including Dallas, Houston, Phoenix, and Washington-Dulles and other regions.
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.